• Immunopathogenesis of liver fibrosis in steatotic liver disease

• Woo Chae-Rin

• Jeong Won-Il

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 299 ~ 302

• Correspondence on Letter regarding ¡°Both liver parenchymal and non-parenchymal cells express JCAD p...

• Jang Byoung-Kuk

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 297 ~ 298

• Harnessing hepatitis B core-related antigen measurement to optimize posttreatment monitoring

• Ying-Nan Tsai

• Jia-Ling Wu, Yao-Chun Hsu

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 293 ~ 296

• Reply to: ¡°Evaluation of the histological scoring systems of autoimmune hepatitis: A significant st...

• Kim Hae-Ryoung

• Jeong Sook-Hyang

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 291 ~ 292

• Correspondence on Editorial regarding ¡°Identification of signature gene set as highly accurate dete...

• Jung Sung-Ju

• Yoon Su-Min, Park Jong-Hoon, Lee Yeon-Su, Yoo Kyung-Hyun

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 287 ~ 290

• In response to: Steatotic liver disease-know your enemies

• Michael H. Le

• Linda Henry, Mindie H. Nguyen

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 284 ~ 286

• Correspondence on Letter regarding ¡°Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIO...

• Hideki Fujii

• Michihiro Iwaki, Yoshihiro Kamada

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 281 ~ 283

• Both liver parenchymal and non-parenchymal cells express JCAD protein under various circumstances

• Li Xie

• Li Zhang, Hui Chen, Yong-Yu Yang, Jian Wu

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 279 ~ 280

• Optimizing off-treatment outcome predictions: The potential of time-varying HBcrAg and the need for ...

• Ying-Nan Tsai

• Jia-Ling Wu, Yao-Chun Hsu

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 276 ~ 278

• Correspondence on Letter regarding ¡°Toward hepatitis C virus elimination using artificial intellige...

• Ming-Ying Lu

• Ming-Lung Yu

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 274 ~ 275

• Letter: Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in pa...

• Hong Hye-Yeon

• Choi Jong-Gi

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 272 ~ 273

• Letter regarding ¡°Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapse...

• Yun-Fan Liaw

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 269 ~ 271

• Similar respiratory function including chronic obstructive pulmonary disease between non-alcoholic f...

• Tsubasa Tsutsumi

• Dan Nakano, Machiko Kawaguchi, Hirokazu Takahashi, Takumi Kawaguchi

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 266 ~ 268

• Changing from NAFLD to MASLD: Similar prognosis of patients with HCC under atezolizumab/bevacizumab ...

• Hiroyuki Suzuki

• Shigeo Shimose, Hideki Iwamoto, Takashi Niizeki, Takumi Kawaguchi

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 263 ~ 265

• Identification of signature gene set as highly accurate determination of metabolic dysfunction-assoc...

• Oh Su-Min

• Baek Yang-Hyun, Jung Sung-Ju, Yoon Su-Min, Kang Byeong-Geun, Han Su-hyang, Park Ga-Eul, Ko...

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 247 ~ 262

• Global incidence of adverse clinical events in nonalcoholic fatty liver disease: A systematic review...

• Michael H. Le

• David M. Le, Thomas C. Baez, Hansen Dang, Vy H. Nguyen, Lee Kee-Seok, Christopher D. Stave,&nbs...

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 235 ~ 246

• Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analy...

• Michihiro Iwaki

• Hideki Fujii, Hideki Hayashi, Hidenori Toyoda, Satoshi Oeda, Hideyuki Hyogo, Miwa Kawanaka,&nbs...

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 225 ~ 234

• JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis

• Li Xie

• Hui Chen, Li Zhang, Yue Ma, Yuan Zhou, Yong-Yu Yang, Chang Liu, Yu-Li Wang, Ya-Jun Ya...

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 206 ~ 224

• Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of ca...

• Jinlin Hou

• Edward Gane, Rozalina Balabanska, Wenhong Zhang, Jiming Zhang, Tien Huey Lim, Qing Xie, Ch...

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 191 ~ 205

• Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellula...

• Miguel Sogb

• Idoia Bilbao, Francesco P. Marchese, Jon Zazpe, Annarosaria De Vito, Marta Pozuelo, Delia D¡¯Av...

• Clinical and Molecular Hepatology   2024  Volume.30  No.2 177 ~ 190